Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity

Affiliations

Comment

J W Young et al. J Exp Med. 1996.

. 1996 Jan 1;183(1):7-11.

doi: 10.1084/jem.183.1.7.

¹ Laboratory of Cellular Physiology and Immunology, Rockefeller University, New York 10021, USA.

No abstract available

Comment on

Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity.
Celluzzi CM, Mayordomo JI, Storkus WJ, Lotze MT, Falo LD Jr. Celluzzi CM, et al. J Exp Med. 1996 Jan 1;183(1):283-7. doi: 10.1084/jem.183.1.283. J Exp Med. 1996. PMID: 8551233 Free PMC article.
Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo.
Paglia P, Chiodoni C, Rodolfo M, Colombo MP. Paglia P, et al. J Exp Med. 1996 Jan 1;183(1):317-22. doi: 10.1084/jem.183.1.317. J Exp Med. 1996. PMID: 8551239 Free PMC article.
Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines.
Zitvogel L, Mayordomo JI, Tjandrawan T, DeLeo AB, Clarke MR, Lotze MT, Storkus WJ. Zitvogel L, et al. J Exp Med. 1996 Jan 1;183(1):87-97. doi: 10.1084/jem.183.1.87. J Exp Med. 1996. PMID: 8551248 Free PMC article.